Prediction model for treatment outcomes 3 years after corneal cross-linking for keratoconus
- PMID: 39302502
- DOI: 10.1007/s10792-024-03301-8
Prediction model for treatment outcomes 3 years after corneal cross-linking for keratoconus
Abstract
Purpose: This study aimed to identify preoperative factors that predict visual acuity and Kmax 3 years after corneal cross-linking (CXL) in patients with keratoconus (KC), and to develop a prediction model.
Methods: We enrolled 68 patients with KC and followed up on 100 eyes that received CXL for at least 3 years. Preoperative data, including age, UDVA, CDVA, cylinder, SE, and the parameters of tomography including Kmax were collected as predictors. The primary outcomes were changes in CDVA (Delta CDVA) and Kmax (Delta Kmax) postoperatively. Univariate and multivariate linear regression were used to identify the correlation between the primary outcomes and predictors and establish prediction models.
Results: Both CDVA and Kmax remained stable from baseline to 3 years after CXL: from 0.25 ± 0.18 to 0.22 ± 0.20 (P = 0.308) and from 58.70 ± 9.52 D to 57.02 ± 8.83 D (P = 0.187), respectively. Multivariate analysis showed that worse preoperative CDVA (ß coefficient - 0.668, P < 0.001) and lower preoperative Kmean (ß coefficient 0.018,P < 0.001) were associated with greater improvement in CDVA after CXL. A smaller preoperative eccentricity (ß coefficient 8.896, P = 0.01) and a higher preoperative Kmean (ß coefficient - 1.264, P < 0.001) predicted a more flattening of postoperative Kmax. The prediction model for CDVA (R2 = 0.43) and Kmax (R2 = 0.37) could accurately estimate treatment outcomes.
Conclusions: CXL is highly effective in halting or preventing further progression of KC. The preoperative factors CDVA and Kmean were able to predict visual acuity changes 3 years after CXL. And preoperative eccentricity and Kmean could predict Kmax changes 3 years after CXL.
Keywords: Corneal cross-linking; Keratoconus; Multivariate analysis; Prediction model.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Effectiveness and safety of accelerated (9 mW/cm2) corneal collagen cross-linking for progressive keratoconus: a 24-month follow-up.Eye (Lond). 2019 May;33(5):812-818. doi: 10.1038/s41433-018-0323-9. Epub 2019 Jan 4. Eye (Lond). 2019. PMID: 30610230 Free PMC article.
-
Assessment of the Predictive Ability of Theranostics for Corneal Cross-linking in Treating Keratoconus: A Randomized Clinical Trial.Ophthalmology. 2024 Dec;131(12):1403-1415. doi: 10.1016/j.ophtha.2024.06.012. Epub 2024 Jun 20. Ophthalmology. 2024. PMID: 38908553 Clinical Trial.
-
Conventional versus accelerated corneal collagen cross-linking in the treatment of keratoconus.Clin Exp Ophthalmol. 2016 Jan-Feb;44(1):8-14. doi: 10.1111/ceo.12571. Epub 2015 Jul 22. Clin Exp Ophthalmol. 2016. PMID: 26140309
-
Pulsed corneal crosslinking in the treatment of Keratoconus: a systematic review and meta-analysis.Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):589-601. doi: 10.1007/s00417-024-06622-7. Epub 2024 Aug 31. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 39215849 Free PMC article.
-
Corneal collagen cross-linking: a review of 1-year outcomes.Eye Contact Lens. 2014 Nov;40(6):345-52. doi: 10.1097/ICL.0000000000000094. Eye Contact Lens. 2014. PMID: 25343263 Review.
Cited by
-
Digital transformation of care for keratoconus patients: ML modeling structural outcomes of corneal collagen cross-linking.Front Med (Lausanne). 2025 Jun 4;12:1462653. doi: 10.3389/fmed.2025.1462653. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40534684 Free PMC article.
References
MeSH terms
Substances
Grants and funding
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. WJ2021M034/The scientific research project of the Health Commission of Hubei Province
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
- Grant No. AR2204D1, NO. AR2004D1/The Research Fund of the Clinical Research Institute of Aier Eye Hospital Group
LinkOut - more resources
Full Text Sources